Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature

Dig Liver Dis. 2018 Apr;50(4):401-407. doi: 10.1016/j.dld.2017.11.003. Epub 2017 Nov 24.

Abstract

Background: Mixed hepatocellular cholangiocarcinoma is a rare form of primary liver cancer.

Aims: The aim of this study is to report the results of the use of contrast enhanced ultrasound in a series of patients with confirmed mixed hepatocellular cholangiocarcinoma and to provide an updated literature review.

Methods: Between January 2012 and October 2016, 25 Asian patients with confirmed mixed hepatocellular cholangiocarcinoma were included in this bicentric retrospective analysis. Clinical data as well recorded images of a standardized conventional B-mode ultrasound and contrast-enhanced ultrasound examination were interpreted by two blinded, independent, experienced radiologists in consensus.

Results: All mixed hepatocellular cholangiocarcinoma lesions were heteroechoic on B-mode ultrasound, with ill-defined margins and irregular shapes. Arterial phase hyperenhancement was present in all 25 patients. Late-phase washout and hypoenhancement was present in 24/25 (96%) patients. However, rim-enhancement and early wash-out (which are common in cholangiocellular carcinoma) were found in over 60% of the cases.

Conclusion: Contrast-enhanced ultrasound demonstrated findings not typical for HCC in a large proportion of patients with confirmed mixed hepatocellular cholangiocarcinoma. Therefore, histological confirmation is crucial, especially in lesions with atypical findings.

Keywords: Contrast-enhanced ultrasound (CEUS); Diagnosis; Differentiate; Mixed hepatocellular cholangiocarcinoma (HCC–CCA);.

Publication types

  • Validation Study

MeSH terms

  • Adult
  • Aged
  • Bile Duct Neoplasms / diagnostic imaging*
  • Bile Duct Neoplasms / pathology
  • Biomarkers, Tumor
  • Carcinoma, Hepatocellular / diagnostic imaging*
  • Carcinoma, Hepatocellular / pathology
  • Cholangiocarcinoma / diagnostic imaging*
  • Cholangiocarcinoma / pathology
  • Female
  • Humans
  • Image Enhancement
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / pathology
  • Male
  • Middle Aged
  • Retrospective Studies
  • Sensitivity and Specificity
  • Ultrasonography / methods

Substances

  • Biomarkers, Tumor